McKesson’s (MCK) fiscal second-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.
2021-10-25
McKesson (MCK) to Report Q2 Earnings: What’s in the Cards?
Previous Post: SITE CENTERS CORP. (SITC) Q3 FFO and Revenues Top Estimates